Quantinno Capital Management
RLAY icon

Quantinno Capital Management’s Relay Therapeutics RLAY Stock Holding History

Quantinno Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$712K Buy
39,440
+2,940
+8% +$56.3K ﹤0.01% 2990
2026
Q2 		$683K Buy
36,500
+15,312
+72% +$222K ﹤0.01% 2812
2026
Q1 		$211K Buy
21,188
+3,911
+23% +$35K ﹤0.01% 3187
2025
Q4 		$146K Buy
17,277
+4,904
+40% +$35K ﹤0.01% 3099
2025
Q3 		$64.6K Buy
+12,373
New +$47.2K ﹤0.01% 2902

Other funds holding RLAY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Quantinno Capital Management's RLAY Position: Q3 2026 in Review

Quantinno Capital Management increased its Relay Therapeutics (RLAY) stake by 8.1% in Q3 2026, buying an estimated $56.3K and bringing the position to 39,440 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #2990.

Quantinno Capital Management first reported a position in RLAY in Q3 2025 and has held it in 5 quarters since. 158 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Quantinno Capital Management held 39,440 shares of Relay Therapeutics worth $712K as of Q3 2026.
  • Quantinno Capital Management bought 2,940 Relay Therapeutics shares in Q3 2026, an estimated $56.3K.
  • Relay Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2990 holding.
  • Quantinno Capital Management first reported a position in Relay Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • 158 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.